# Re‐induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2

> Research article (Pediatric Blood & Cancer, 2015) · cited 98× · AI/ML

**Wikidata**: [openalex:W2159877301](https://www.wikidata.org/wiki/openalex:W2159877301)  
**Source**: https://4ort.xyz/entity/reinduction-chemoimmunotherapy-with-epratuzumab-in-relapsed-acute-lymphoblastic-leukemia-all-phase-ii-results-from-child